Acquired Company
Radius Health was acquired by Gurnet Point Capital and Patient Square Capital for $10.00 per share in cash plus a Contingent Value Right (CVR), and the merger was completed on August 15, 2022, after which Radius Health became a private company.
Radius Health, Inc., a biopharmaceutical company, develops and markets endocrine and other therapeutic products. The company is headquartered in Boston, Massachusetts. Show more
299 SW CLAY STREET, PORTLAND, OR, UNITED STATES, 97201, Portland, OR, 97201, USA
Market Cap
847.7M
52 Wk Range
$0.00 - $0.00
Previous Close
$30.00
Open
$30.00
Volume
N/A
Day Range
$30.00 - $30.00
Enterprise Value
1.416B
Cash
16.21M
Avg Qtr Burn
N/A
Insider Ownership
6.45%
Institutional Own.
-
Qtr Updated
05/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|